PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
57.79%
Revenue growth exceeding 1.5x VET's 0.66%. David Dodd would verify if faster growth reflects superior business model.
-13.42%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
142.67%
Gross profit growth exceeding 1.5x VET's 10.12%. David Dodd would verify competitive advantages.
53.79%
Margin expansion exceeding 1.5x VET's 9.40%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
2.27%
Similar G&A growth to VET's 2.94%. Walter Schloss would investigate industry cost structures.
No Data
No Data available this quarter, please select a different quarter.
4044.44%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
-3.73%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-8.68%
Both companies reducing total costs. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
1.63%
D&A growth while VET reduces D&A. John Neff would investigate differences.
1920.59%
EBITDA growth exceeding 1.5x VET's 102.41%. David Dodd would verify competitive advantages.
81.59%
EBITDA margin growth exceeding 1.5x VET's 1.30%. David Dodd would verify competitive advantages.
1020.37%
Operating income growth exceeding 1.5x VET's 156.80%. David Dodd would verify competitive advantages.
683.30%
Operating margin growth exceeding 1.5x VET's 155.12%. David Dodd would verify competitive advantages.
76.19%
Other expenses growth above 1.5x VET's 3.55%. Michael Burry would check for concerning trends.
272.91%
Similar pre-tax income growth to VET's 278.48%. Walter Schloss would investigate industry trends.
209.58%
Similar pre-tax margin growth to VET's 277.32%. Walter Schloss would investigate industry trends.
-90.00%
Tax expense reduction while VET shows 199.08% growth. Joel Greenblatt would examine advantage.
253.38%
Net income growth below 50% of VET's 1204.66%. Michael Burry would check for structural issues.
197.21%
Net margin growth below 50% of VET's 1197.44%. Michael Burry would check for structural issues.
234.15%
EPS growth below 50% of VET's 1217.65%. Michael Burry would check for structural issues.
234.15%
Diluted EPS growth below 50% of VET's 1207.78%. Michael Burry would check for structural issues.
13.36%
Share count change of 13.36% while VET is stable. Bruce Berkowitz would verify approach.
13.36%
Diluted share change of 13.36% while VET is stable. Bruce Berkowitz would verify approach.